{"bottlenecks":[{"tag":"[P]","color":"#a4c2f4","Q2 Bottleneck":"[P] Public","# (bottlenecks only)":"72","# all a":"78","Bottleneck Description":"Social bottlenecks from outside the longevity community"},{"tag":"[P1]","color":"#c9daf8","Q2 Bottleneck":"[P1] Poorly Informed","# (bottlenecks only)":"21","# all a":"21","Bottleneck Description":"General public is generally unaware of or misonfirmed about the science, tech and future possibilities."},{"tag":"[P2]","color":"#c9daf8","Q2 Bottleneck":"[P2] Individual Disease Focus","# (bottlenecks only)":"17","# all a":"20","Bottleneck Description":"Focus on age-related diseases rather than their root cause (aging)."},{"tag":"[P3]","color":"#c9daf8","Q2 Bottleneck":"[P3] Lack of Credibility","# (bottlenecks only)":"9","# all a":"10","Bottleneck Description":"Public skepticism with good cause, history of charlatanism, snake oil, ineffective \"anti-aging\" treatments."},{"tag":"[P4]","color":"#c9daf8","Q2 Bottleneck":"[P4] Unaligned Institutions","# (bottlenecks only)":"10","# all a":"10","Bottleneck Description":"Lack of mandate, interest and even obstruction by gov agencies, academia, media, healthcare orgs, etc."},{"tag":"[P5]","color":"#c9daf8","Q2 Bottleneck":"[P5] Geroscience Aversion","# (bottlenecks only)":"6","# all a":"8","Bottleneck Description":"Stigma, \"pro-aging trance\", naturalistic fallacy, culture of dystopianism / tech skepticism."},{"tag":"[P6]","color":"#c9daf8","Q2 Bottleneck":"[P6] Indifference","# (bottlenecks only)":"7","# all a":"7","Bottleneck Description":"Apathy, laziness, or bystander effect (failure to take responsibility / thinking someone else will solve it)."},{"tag":"[P7]","color":"#c9daf8","Q2 Bottleneck":"[P7] Media Negativity","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"Preferencial amplification of negative sentiments, which become the default public opinion by osmosis."},{"tag":"[C]","color":"#b6d7a8","Q2 Bottleneck":"[C] Community","# (bottlenecks only)":"151","# all a":"165","Bottleneck Description":"How we dysfunction as a community"},{"tag":"[C1]","color":"#d9ead3","Q2 Bottleneck":"[C1] Lack of Big Data Mindset","# (bottlenecks only)":"10","# all a":"11","Bottleneck Description":"More focus on empirical data collection: Multio-omics, images, phenotypes, medical, longititual, clinical, etc."},{"tag":"[C2]","color":"#d9ead3","Q2 Bottleneck":"[C2] Ad-hoc Data / Protocols","# (bottlenecks only)":"15","# all a":"20","Bottleneck Description":"Ad-hoc data/protocols (not reproducible or comparable) prevents integration and building on prior results."},{"tag":"[C3]","color":"#d9ead3","Q2 Bottleneck":"[C3] Networking","# (bottlenecks only)":"11","# all a":"11","Bottleneck Description":" Isolated people/projects/subdisciplines, need for more networking and connection."},{"tag":"[C4]","color":"#d9ead3","Q2 Bottleneck":"[C4] Lack of Collective Action","# (bottlenecks only)":"9","# all a":"10","Bottleneck Description":"Lack of collective actions such as consensus building, validation, data sharing, standards, roadmapping, etc."},{"tag":"[C5]","color":"#d9ead3","Q2 Bottleneck":"[C5] Consensus Aging Definitions","# (bottlenecks only)":"11","# all a":"12","Bottleneck Description":"Lack of a consensus definition of aging."},{"tag":"[C6]","color":"#d9ead3","Q2 Bottleneck":"[C6] Hype Cycles","# (bottlenecks only)":"11","# all a":"11","Bottleneck Description":"Hype cycles + herd mentality = inefficient distro of resources, short term booms and busts of interest/funding."},{"tag":"[C7]","color":"#d9ead3","Q2 Bottleneck":"[C7] Regional Concentration","# (bottlenecks only)":"8","# all a":"10","Bottleneck Description":"Activity is heavily concentrated in a small number of extremely expensive places."},{"tag":"[C8]","color":"#d9ead3","Q2 Bottleneck":"[C8] Reproducibility Crisis","# (bottlenecks only)":"12","# all a":"12","Bottleneck Description":"System incentivizes sloppy research and doesn't penalize poor quality."},{"tag":"[C9]","color":"#d9ead3","Q2 Bottleneck":"[C9] Insularity","# (bottlenecks only)":"13","# all a":"14","Bottleneck Description":"Aging/longevity has been an insulated backwater - need to emerge, mature and engage with other fields."},{"tag":"[C10]","color":"#d9ead3","Q2 Bottleneck":"[C10] Siloing / Secrecy","# (bottlenecks only)":"13","# all a":"14","Bottleneck Description":"Academic grant, IP, and publication systems can over-incentivize competition/secrecy over collaboration."},{"tag":"[C11]","color":"#d9ead3","Q2 Bottleneck":"[C11] Conservatism","# (bottlenecks only)":"8","# all a":"8","Bottleneck Description":"Sticking to worn out hypotheses / following authority after they are past their prime (ex. beta amyloid)"},{"tag":"[C12]","color":"#d9ead3","Q2 Bottleneck":"[C12] Lack of Negative Results","# (bottlenecks only)":"6","# all a":"7","Bottleneck Description":"System dis-incentivize negative result reporting. Results in duplicated efforts, and rewards hype."},{"tag":"[C13]","color":"#d9ead3","Q2 Bottleneck":"[C13] Entry Barriers/Orientation","# (bottlenecks only)":"6","# all a":"7","Bottleneck Description":"Hard learn / track of all the activity, regulations, systems at R&D, translation, clinical and healthcare levels."},{"tag":"[C14]","color":"#d9ead3","Q2 Bottleneck":"[C14] Piecemeal Studies","# (bottlenecks only)":"7","# all a":"7","Bottleneck Description":"Narrow/reductionist \"piecemeal\" studies fail to address the complexity of aging."},{"tag":"[C15]","color":"#d9ead3","Q2 Bottleneck":"[C15] Admin Overhead","# (bottlenecks only)":"4","# all a":"4","Bottleneck Description":"Bright scienetific minds are frequently being wasted on administrative burdens instead of doing science."},{"tag":"[C16]","color":"#d9ead3","Q2 Bottleneck":"[C16] Journal Paywalls","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"Obvious and unnecessary barrier to the spread of scientific information."},{"tag":"[C17]","color":"#d9ead3","Q2 Bottleneck":"[C17] Short-termism","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"Over-focus on \"low hanging fruit\" that is also low-impact. Starves high impact projects of resources."},{"tag":"[C18]","color":"#d9ead3","Q2 Bottleneck":"[C18] Misc Community Issues","# (bottlenecks only)":"3","# all a":"3","Bottleneck Description":""},{"tag":"[S]","color":"#ffe599","Q2 Bottleneck":"[S] Science","# (bottlenecks only)":"130","# all a":"140","Bottleneck Description":"Areas that need more basic scientific research."},{"tag":"[S1]","color":"#fff2cc","Q2 Bottleneck":"[S1] Validated Biomarkers","# (bottlenecks only)":"40","# all a":"44","Bottleneck Description":"Lack of a validated way to measure biological age independent of chronological age / lifespan."},{"tag":"[S2]","color":"#fff2cc","Q2 Bottleneck":"[S2] Aging Characterization","# (bottlenecks only)":"20","# all a":"22","Bottleneck Description":"Characterization of what changes with age at the molecular/cellular/tissue/physiology levels."},{"tag":"[S3]","color":"#fff2cc","Q2 Bottleneck":"[S3] Longitudinal Data/Samples","# (bottlenecks only)":"14","# all a":"17","Bottleneck Description":"Lack of longitudinal data and samples (clinical records, biomarkers, multi-omics, biobanks)."},{"tag":"[S4]","color":"#fff2cc","Q2 Bottleneck":"[S4] Aging Complexity","# (bottlenecks only)":"12","# all a":"12","Bottleneck Description":"Complexity of aging is too much for traditional tools and institutional structures to grapple with effectively."},{"tag":"[S5]","color":"#fff2cc","Q2 Bottleneck":"[S5] Variation Mapping","# (bottlenecks only)":"12","# all a":"13","Bottleneck Description":"Need for more studies on intra & inter-species longevity variability and intervention responses."},{"tag":"[S6]","color":"#fff2cc","Q2 Bottleneck":"[S6] Misc","# (bottlenecks only)":"8","# all a":"8","Bottleneck Description":"Assorted other science bottlenecks / under-appreciated areas"},{"tag":"[S7]","color":"#fff2cc","Q2 Bottleneck":"[S7] Systems Bio of Aging","# (bottlenecks only)":"9","# all a":"9","Bottleneck Description":"Need for more systems/network approach studyies of aging."},{"tag":"[S8]","color":"#fff2cc","Q2 Bottleneck":"[S8] Brain Aging","# (bottlenecks only)":"4","# all a":"4","Bottleneck Description":"Every other part could potentially be replaced, therefore brain aging is critical to understand."},{"tag":"[S9]","color":"#fff2cc","Q2 Bottleneck":"[S9] Aging Mechanisms","# (bottlenecks only)":"11","# all a":"11","Bottleneck Description":"Belief that we don't yet understand what aging is, need to determine the fundamental mechanisms."},{"tag":"[S10]","color":"#fff2cc","Q2 Bottleneck":"[S10] Replacement","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"Learn how to grow and replace any/all biological parts"},{"tag":"[F]","color":"#d5a6bd","Q2 Bottleneck":"[F] Funding","# (bottlenecks only)":"119","# all a":"131","Bottleneck Description":""},{"tag":"[F0]","color":"#ead1dc","Q2 Bottleneck":"[F0] Overall Lack of Funding","# (bottlenecks only)":"40","# all a":"44","Bottleneck Description":"We need Apollo program levels of funding - measured in % of GDP not in $Bs"},{"tag":"[F1]","color":"#ead1dc","Q2 Bottleneck":"[F1] Too Conservative","# (bottlenecks only)":"22","# all a":"26","Bottleneck Description":"Difficult to get new/ambitious ideas funded, institutional culture of risk-aversion and incrementalism."},{"tag":"[F2]","color":"#ead1dc","Q2 Bottleneck":"[F2] for Basic Research","# (bottlenecks only)":"18","# all a":"19","Bottleneck Description":"Longevity/aging is only 0.5% of NIH budget, even smaller elsewhere."},{"tag":"[F3]","color":"#ead1dc","Q2 Bottleneck":"[F3] Too Short-term","# (bottlenecks only)":"10","# all a":"12","Bottleneck Description":"Lifespan studies in the most relevant models take longer than standard grant cycles."},{"tag":"[F4]","color":"#ead1dc","Q2 Bottleneck":"[F4] for Startups","# (bottlenecks only)":"9","# all a":"9","Bottleneck Description":"Longevity Biotech is only 1% of total Biotech Market Cap, huge room for growth."},{"tag":"[F5]","color":"#ead1dc","Q2 Bottleneck":"[F5] Gated","# (bottlenecks only)":"6","# all a":"7","Bottleneck Description":"Hard to get funds if you're not from a top institution / company"},{"tag":"[F6]","color":"#ead1dc","Q2 Bottleneck":"[F6] for Translation","# (bottlenecks only)":"6","# all a":"6","Bottleneck Description":"Not enough funding for translating basic research results to real world applications."},{"tag":"[F7]","color":"#ead1dc","Q2 Bottleneck":"[F7] Inflexible","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"Easier to get grants for continued work vs new directions. Incentives to stay the course even if not promising."},{"tag":"[F8]","color":"#ead1dc","Q2 Bottleneck":"[F8] for Outreach","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"Funding for media and outreach to engage, educate, and attract the public and other communities."},{"tag":"[F9]","color":"#ead1dc","Q2 Bottleneck":"[F9] for Clinical/Longitudinal","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"Clinical and longitudinal studies are bureaucratically difficult, expensive, and hard to get funded."},{"tag":"[F10]","color":"#ead1dc","Q2 Bottleneck":"[F10] Bureaucratic/Slow","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"High bureaucracy doesn’t improve decision making, it just wastes people’s time."},{"tag":"[H]","color":"#f9cb9c","Q2 Bottleneck":"[H] People","# (bottlenecks only)":"99","# all a":"102","Bottleneck Description":""},{"tag":"[H0]","color":"#fce5cd","Q2 Bottleneck":"[H0] Lack of People","# (bottlenecks only)":"15","# all a":"15","Bottleneck Description":"Not enough people working in or entering the field."},{"tag":"[H1]","color":"#fce5cd","Q2 Bottleneck":"[H1] Career & Edu Paths","# (bottlenecks only)":"17","# all a":"17","Bottleneck Description":"Lack of education and career paths by existing institutions."},{"tag":"[H2]","color":"#fce5cd","Q2 Bottleneck":"[H2] Low Pay","# (bottlenecks only)":"6","# all a":"8","Bottleneck Description":"Need to pay people more to make careers in our field sustainable, and to compete for top talent."},{"tag":"[H3]","color":"#fce5cd","Q2 Bottleneck":"[H3] Quantitative","# (bottlenecks only)":"7","# all a":"7","Bottleneck Description":"Biology has been a \"soft/artisinal\" science - need to grow up, accelerate the shift to quantitative approaches."},{"tag":"[H4]","color":"#fce5cd","Q2 Bottleneck":"[H4] Top/Skilled Talent","# (bottlenecks only)":"22","# all a":"22","Bottleneck Description":"Top talent can have outsized effects, and is currently not focused on longevity."},{"tag":"[H6]","color":"#fce5cd","Q2 Bottleneck":"[H6] Immigration/Borders","# (bottlenecks only)":"4","# all a":"5","Bottleneck Description":"Immigration/border restrictions are hampering efficient allocaiton of human resources."},{"tag":"[H7]","color":"#fce5cd","Q2 Bottleneck":"[H7] Hiring","# (bottlenecks only)":"4","# all a":"4","Bottleneck Description":"Hiring people is time consuming and error-prone."},{"tag":"[H8]","color":"#fce5cd","Q2 Bottleneck":"[H8] Interdisciplinary","# (bottlenecks only)":"6","# all a":"6","Bottleneck Description":"Need more interdisciplinary overlaps for fresh perspective."},{"tag":"[H9]","color":"#fce5cd","Q2 Bottleneck":"[H9] Personal/Misc","# (bottlenecks only)":"18","# all a":"18","Bottleneck Description":""},{"tag":"[X]","color":"#a2c4c9","Q2 Bottleneck":"[X] Tools","# (bottlenecks only)":"173","# all a":"196","Bottleneck Description":""},{"tag":"[X0]","color":"#d0e0e3","Q2 Bottleneck":"[X0] Lack of Misc Tools/Tech","# (bottlenecks only)":"4","# all a":"5","Bottleneck Description":"Not enough Tools and Technology development in general."},{"tag":"[X1.1]","color":"#d0e0e3","Q2 Bottleneck":"[X1.1] Lack of Predictive Models","# (bottlenecks only)":"32","# all a":"33","Bottleneck Description":"Current molel organisms are poorly predictive of results in humans."},{"tag":"[X1.2]","color":"#d0e0e3","Q2 Bottleneck":"[X1.2] Slow & Expensive Models","# (bottlenecks only)":"36","# all a":"36","Bottleneck Description":"Animal model studies are slow and expensive."},{"tag":"[X1.3]","color":"#d0e0e3","Q2 Bottleneck":"[X1.3] Lack of In Silico/Systems Aging Models","# (bottlenecks only)":"10","# all a":"10","Bottleneck Description":"More complex/comprehensive computer models describing or predicting the processes of aging."},{"tag":"[X2]","color":"#d0e0e3","Q2 Bottleneck":"[X2] Public Datasets","# (bottlenecks only)":"27","# all a":"35","Bottleneck Description":"Lack of accessible and comprehensive data sets."},{"tag":"[X3]","color":"#d0e0e3","Q2 Bottleneck":"[X3] Human Samples","# (bottlenecks only)":"11","# all a":"13","Bottleneck Description":"Access to human samples (healthy, aged, diseased, with good sample info) is difficult, slow and expensive."},{"tag":"[X4]","color":"#d0e0e3","Q2 Bottleneck":"[X4] Aged Animals/Tissues","# (bottlenecks only)":"11","# all a":"14","Bottleneck Description":"Access aged animals and their tissues/cells is difficult, slow and expensive."},{"tag":"[X5]","color":"#d0e0e3","Q2 Bottleneck":"[X5] Instrumentation/Lab Tech","# (bottlenecks only)":"10","# all a":"14","Bottleneck Description":"Lab tech is expensive, difficult to use, often unreliable. Better/cheaper/new HW enables progress."},{"tag":"[X6]","color":"#d0e0e3","Q2 Bottleneck":"[X6] Lab Automation","# (bottlenecks only)":"8","# all a":"8","Bottleneck Description":"Lab automation is expensive and not user friendly - better tech would improve research throughput & quality"},{"tag":"[X7]","color":"#d0e0e3","Q2 Bottleneck":"[X7] CS / Software","# (bottlenecks only)":"4","# all a":"7","Bottleneck Description":"Research software is expensive, proprietary, buggy and not user friendly."},{"tag":"[X8]","color":"#d0e0e3","Q2 Bottleneck":"[X8] Gene Delivery","# (bottlenecks only)":"5","# all a":"5","Bottleneck Description":"Need improvements in toxicity, biodistribution, payload size, immunogenicity, transfection efficiency & more."},{"tag":"[X9]","color":"#d0e0e3","Q2 Bottleneck":"[X9] Research Infrastructure","# (bottlenecks only)":"4","# all a":"4","Bottleneck Description":"Lab space is expensive, scarce, difficult to access."},{"tag":"[X10]","color":"#d0e0e3","Q2 Bottleneck":"[X10] AI Tools","# (bottlenecks only)":"3","# all a":"4","Bottleneck Description":"Maybe humans can't parse bio, need AI to accelerate progress"},{"tag":"[X11]","color":"#d0e0e3","Q2 Bottleneck":"[X11] Personal Health Sensors","# (bottlenecks only)":"3","# all a":"3","Bottleneck Description":"Cars have hundreds of sensors. Most people have none. They need to be cheaper, non-invasive, easier to use."},{"tag":"[X12]","color":"#d0e0e3","Q2 Bottleneck":"[X12] Personal Health Data Sharing","# (bottlenecks only)":"3","# all a":"3","Bottleneck Description":"Current options are expensive, siloed, difficult to use, disconnected from research."},{"tag":"[X13]","color":"#d0e0e3","Q2 Bottleneck":"[X13] Computing Power","# (bottlenecks only)":"2","# all a":"2","Bottleneck Description":"More compute power unlocks new research capabilities. Also needs to be accessible."},{"tag":"[X14]","color":"#d0e0e3","Q2 Bottleneck":"[X14] Information Overload","# (bottlenecks only)":"1","# all a":"2","Bottleneck Description":"Too many papers for a human to read/parse even if you spend all day every day."},{"tag":"[T]","color":"#b4a7d6","Q2 Bottleneck":"[T] Translation","# (bottlenecks only)":"95","# all a":"104","Bottleneck Description":""},{"tag":"[T1]","color":"#d9d2e9","Q2 Bottleneck":"[T1] Lack of Regulatory Path","# (bottlenecks only)":"30","# all a":"38","Bottleneck Description":"No current regulatory path for aging interventions / longevity medicine."},{"tag":"[T2]","color":"#d9d2e9","Q2 Bottleneck":"[T2] Translation Gap","# (bottlenecks only)":"27","# all a":"27","Bottleneck Description":"Lack of translation of basic research results into actual therapies."},{"tag":"[T3]","color":"#d9d2e9","Q2 Bottleneck":"[T3] Slow/Expensive Trials","# (bottlenecks only)":"10","# all a":"10","Bottleneck Description":"Clinical trials (as currently practiced) are slow and expensive."},{"tag":"[T4]","color":"#d9d2e9","Q2 Bottleneck":"[T4] Misguided \"Bioethics\"","# (bottlenecks only)":"9","# all a":"10","Bottleneck Description":"Risk aversion / harmful action reduction mindset ignores the harm of inaction / slowed progress."},{"tag":"[T5]","color":"#d9d2e9","Q2 Bottleneck":"[T5] Market Failure","# (bottlenecks only)":"11","# all a":"11","Bottleneck Description":"\"Sick-care\" system maximizes money spent not health/lifespan outcomes, needs structural redesign."},{"tag":"[T6]","color":"#d9d2e9","Q2 Bottleneck":"[T6] Participant Recruitment","# (bottlenecks only)":"5","# all a":"5","Bottleneck Description":"Recruit participants to trials and clinical studies is slow, expensive, bureaocratic."},{"tag":"[T7]","color":"#d9d2e9","Q2 Bottleneck":"[T7] Unregulated Claims","# (bottlenecks only)":"3","# all a":"3","Bottleneck Description":"Pervasive hyped therapies with little to no evidence (NAD, MSCs, diets, hot/cold therapy, light therapy, etc.)"}],"solutions":[{"tag":"[+P]","color":"#a4c2f4","Q3 Solution":"[+P] Public","# solutions only":"30","# all b":"48","Solution Description":"Social projects aimed outside of the longevity community"},{"tag":"[+P1.1]","color":"#c9daf8","Q3 Solution":"[+P1.1] Outreach to Public","# solutions only":"11","# all b":"15","Solution Description":"Shift public sentiment towards pro-longevity. Cascading benefits (policy, funding, market, career choice...)"},{"tag":"[+P1.2]","color":"#c9daf8","Q3 Solution":"[+P1.2] Outreach to Other Fields","# solutions only":"2","# all b":"6","Solution Description":"Bring fresh persepctives and skillsets into the longevity movement."},{"tag":"[+P1.3]","color":"#c9daf8","Q3 Solution":"[+P1.3] Outreach to Biotech/Pharma","# solutions only":"1","# all b":"3","Solution Description":"Only 1% of Biotech/Pharma is longevity/aging oriented, lots of room for growth."},{"tag":"[+P1.4]","color":"#c9daf8","Q3 Solution":"[+P1.4] Outreach to Students","# solutions only":"0","# all b":"1","Solution Description":"Deflect career paths at the highest leverage point."},{"tag":"[+P1.5]","color":"#c9daf8","Q3 Solution":"[+P1.5] Outreach to Gov/Institutions","# solutions only":"3","# all b":"4","Solution Description":"Engage/infiltrate to improve alignment. They have the power to break many bottlenecks if aligned."},{"tag":"[+P2]","color":"#c9daf8","Q3 Solution":"[+P2] Culture","# solutions only":"10","# all b":"11","Solution Description":"A widespread pro-longevity cultural movement."},{"tag":"[+P3]","color":"#c9daf8","Q3 Solution":"[+P3] Incentives","# solutions only":"2","# all b":"5","Solution Description":"Regulations/policies to incentivize longevity practices/industry growth - works for climate why not longevity?"},{"tag":"[+P4]","color":"#c9daf8","Q3 Solution":"[+P4] Comms Training","# solutions only":"1","# all b":"3","Solution Description":"For scientists, engineers, operators in longevity - training to communicate clearly and effectively to the public."},{"tag":"[+C]","color":"#b6d7a8","Q3 Solution":"[+C] Community","# solutions only":"73","# all b":"107","Solution Description":"How we could improve functioning of the community"},{"tag":"[+C1]","color":"#d9ead3","Q3 Solution":"[+C1] Big Data Mindset","# solutions only":"2","# all b":"5","Solution Description":"More focus on empirical data collection: Multio-omics, images, phenotypes, medical, longititual, clinical, etc."},{"tag":"[+C2]","color":"#d9ead3","Q3 Solution":"[+C2] Data/Protocol Standards","# solutions only":"11","# all b":"18","Solution Description":"Set and update standards for data and protocols, incentivize their use."},{"tag":"[+C3]","color":"#d9ead3","Q3 Solution":"[+C3] Networking","# solutions only":"13","# all b":"16","Solution Description":"Mechanism to connect employers, entrepreneurs, investors, volunteers, etc."},{"tag":"[+C4]","color":"#d9ead3","Q3 Solution":"[+C4] Large Collaborative Projects","# solutions only":"8","# all b":"13","Solution Description":"Large collaborative projects and rather than ego/grant/publication driven competition."},{"tag":"[+C5]","color":"#d9ead3","Q3 Solution":"[+C5] Collective Action","# solutions only":"8","# all b":"11","Solution Description":"Organize to facilitate consensus building, validation, data sharing, standards, roadmapping, etc."},{"tag":"[+C6]","color":"#d9ead3","Q3 Solution":"[+C6] Consensus Aging Definition","# solutions only":"6","# all b":"12","Solution Description":"Reach a consensus theory/definition of aging"},{"tag":"[+C7]","color":"#d9ead3","Q3 Solution":"[+C7] New Research Centers","# solutions only":"6","# all b":"8","Solution Description":"More dedicated aging/longevity research centers. Diverse locations. Varied specialties. Facilitate large projects."},{"tag":"[+C8]","color":"#d9ead3","Q3 Solution":"[+C8] Reproduce Key Results","# solutions only":"3","# all b":"6","Solution Description":"Funded centers dedicated to reproducing / testing the robustness of key results."},{"tag":"[+C9]","color":"#d9ead3","Q3 Solution":"[+C9] Field-Wide Status Dashboard","# solutions only":"7","# all b":"7","Solution Description":"Overview of all proposals, projects, pathways, targets, pre and in-clinic pipelines. Linked to data."},{"tag":"[+C10]","color":"#d9ead3","Q3 Solution":"[+C10] Outsourcing Services","# solutions only":"4","# all b":"6","Solution Description":"Longevity CROs/Cores - make outsourcing research easier such as lifespan studies, multi-omic analysis."},{"tag":"[+C11]","color":"#d9ead3","Q3 Solution":"[+C11] Neg Results Incentives","# solutions only":"3","# all b":"4","Solution Description":"Mechanism to incentivize/enable reporting negative results. Pre-results publication approvals for example."},{"tag":"[+C12]","color":"#d9ead3","Q3 Solution":"[+C12] Open Science","# solutions only":"1","# all b":"2","Solution Description":"Make data, samples, results open and available by default."},{"tag":"[+C13]","color":"#d9ead3","Q3 Solution":"[+C13] Long-termism","# solutions only":"1","# all b":"2","Solution Description":"More focus on long term research and technology paths with higher-impact potential (vs \"low hanging fruit\")"},{"tag":"[+C14]","color":"#d9ead3","Q3 Solution":"[+C14] Protected Time","# solutions only":"1","# all b":"1","Solution Description":"Reduce/limit the amount of time spent on non-research activities (admin, grants, etc.)"},{"tag":"[+C15]","color":"#d9ead3","Q3 Solution":"[+C15] Leadership","# solutions only":"1","# all b":"1","Solution Description":"Bold and ambitious, yet free of ego/hype and relatable. Leadership is lacking but necessary to build a movement."},{"tag":"[+S]","color":"#ffe599","Q3 Solution":"[+S] Science","# solutions only":"35","# all b":"80","Solution Description":"Research goals, that if achieved would unlock progress."},{"tag":"[+S1]","color":"#fff2cc","Q3 Solution":"[+S1] Validated Biomarkers","# solutions only":"13","# all b":"41","Solution Description":"Validated way to measure biological age independent of chronological age / lifespan."},{"tag":"[+S2]","color":"#fff2cc","Q3 Solution":"[+S2] Aging Fully Characterized","# solutions only":"10","# all b":"15","Solution Description":"Comprehensive characterization of aging at the molecular/cellular/tissue/physiology levels."},{"tag":"[+S3]","color":"#fff2cc","Q3 Solution":"[+S3] Longitudinal Data/Samples","# solutions only":"8","# all b":"16","Solution Description":"Unlock or generate more longitudinal data and samples (clinical records, biomarkers, multi-omics, biobanks)"},{"tag":"[+S4]","color":"#fff2cc","Q3 Solution":"[+S4] Aging Variation Mapped","# solutions only":"3","# all b":"4","Solution Description":"Comprehensive map of Intra and inter species aging variation (omics, physiology, phenotype, etc.)"},{"tag":"[+S10]","color":"#fff2cc","Q3 Solution":"[+S10] Brain Rejuvenation/Replacement","# solutions only":"1","# all b":"4","Solution Description":"Ambitious and broad range of R&D on brain rejuvenation/replacement."},{"tag":"[+S11]","color":"#fff2cc","Q3 Solution":"[+S11] Comprehensive Replacement","# solutions only":"0","# all b":"2","Solution Description":"Methods to grow and replace any/all biological parts"},{"tag":"[+F]","color":"#d5a6bd","Q3 Solution":"[+F] Funding","# solutions only":"47","# all b":"124","Solution Description":""},{"tag":"[+F0]","color":"#ead1dc","Q3 Solution":"[+F0] Overall More Funding","# solutions only":"18","# all b":"44","Solution Description":"We need Apollo program levels of funding - measured in % of GDP not in $Bs"},{"tag":"[+F1]","color":"#ead1dc","Q3 Solution":"[+F1] Ambitious/Exploratory","# solutions only":"11","# all b":"21","Solution Description":"More ambitious/exploratory projects are needed to accelerate progress."},{"tag":"[+F2]","color":"#ead1dc","Q3 Solution":"[+F2] for Basic Research","# solutions only":"5","# all b":"20","Solution Description":"Longevity/aging is only 0.5% of NIH budget, even smaller elsewhere."},{"tag":"[+F3]","color":"#ead1dc","Q3 Solution":"[+F3] Longer-term","# solutions only":"6","# all b":"13","Solution Description":"Longer bets on people and projects are necessary for many aging research directions."},{"tag":"[+F4]","color":"#ead1dc","Q3 Solution":"[+F4] for Startups","# solutions only":"3","# all b":"7","Solution Description":"Longevity Biotech is only 1% of total Biotech Market Cap, huge room for growth."},{"tag":"[+F5]","color":"#ead1dc","Q3 Solution":"[+F5] for Outsiders","# solutions only":"1","# all b":"6","Solution Description":"Take more bets on system outsiders (non-academic / non-ivy league)."},{"tag":"[+F6]","color":"#ead1dc","Q3 Solution":"[+F6] for Translation","# solutions only":"1","# all b":"4","Solution Description":"Not enough funding for translating basic research results to real world applications."},{"tag":"[+F7]","color":"#ead1dc","Q3 Solution":"[+F7] Flexible","# solutions only":"1","# all b":"3","Solution Description":"Grants for promising people to transition from other fields/areas."},{"tag":"[+F8]","color":"#ead1dc","Q3 Solution":"[+F8] for Outreach","# solutions only":"0","# all b":"2","Solution Description":"Funding for media and outreach to engage, educate, and attract the public and other communities."},{"tag":"[+F9]","color":"#ead1dc","Q3 Solution":"[+F9] for Clinical/Longitudinal","# solutions only":"0","# all b":"2","Solution Description":"Clinical and longitudinal studies are bureaucratically difficult, expensive, and hard to get funded."},{"tag":"[+F10]","color":"#ead1dc","Q3 Solution":"[+F10] Faster Grants","# solutions only":"1","# all b":"2","Solution Description":"High bureaucracy doesn’t improve decision making, it just wastes people’s time."},{"tag":"[+H]","color":"#f9cb9c","Q3 Solution":"[+H] People","# solutions only":"18","# all b":"46","Solution Description":""},{"tag":"[+H0]","color":"#fce5cd","Q3 Solution":"[+H0] More People","# solutions only":"2","# all b":"14","Solution Description":"Not enough people working in or entering the field."},{"tag":"[+H1]","color":"#fce5cd","Q3 Solution":"[+H1] Quantitative","# solutions only":"1","# all b":"8","Solution Description":"Need to recruit or train more people in quantitative skills (math, physics, statistics, ml, comp/systems bio)"},{"tag":"[+H2]","color":"#fce5cd","Q3 Solution":"[+H2] Higher Pay","# solutions only":"3","# all b":"7","Solution Description":"Need to pay people more to make careers in our field sustainable, and to compete for top talent."},{"tag":"[+H3]","color":"#fce5cd","Q3 Solution":"[+H3] Longevity Training","# solutions only":"2","# all b":"5","Solution Description":"We need edu/career paths for people to start or shift careers in longevity biotech."},{"tag":"[+H4]","color":"#fce5cd","Q3 Solution":"[+H4] Skills Assessment","# solutions only":"2","# all b":"2","Solution Description":"Better alternatives to degrees/resumes/interviews? Get people to work faster and more efficiently."},{"tag":"[+H5]","color":"#fce5cd","Q3 Solution":"[+H5] Interdisciplinary","# solutions only":"1","# all b":"3","Solution Description":"Need more interdisciplinary overlaps for fresh perspective."},{"tag":"[+H6]","color":"#fce5cd","Q3 Solution":"[+H6] More/Flexible Visas","# solutions only":"1","# all b":"1","Solution Description":"Immigration/border restrictions are hampering efficient allocaiton of human resources."},{"tag":"[+H10]","color":"#fce5cd","Q3 Solution":"[+H10] Personal/Misc","# solutions only":"4","# all b":"4","Solution Description":"Misc personal solutions"},{"tag":"[+H9]","color":"#fce5cd","Q3 Solution":"[+H9] Top/Skilled Talent","# solutions only":"2","# all b":"2","Solution Description":"Top talent can have outsized effects, and is currently not focused on longevity."},{"tag":"[+X]","color":"#a2c4c9","Q3 Solution":"[+X] Tools","# solutions only":"79","# all b":"161","Solution Description":""},{"tag":"[+X0]","color":"#d0e0e3","Q3 Solution":"[+X0] Unspecified Tools/Tech","# solutions only":"1","# all b":"4","Solution Description":"More Tools and Technology development in general."},{"tag":"[+X1.1]","color":"#d0e0e3","Q3 Solution":"[+X1.1] In Silico/Systems Aging Models","# solutions only":"4","# all b":"15","Solution Description":"Computational/Systems Bio Modeling. Make predictions in silico to save time and cost in meatspace."},{"tag":"[+X1.2]","color":"#d0e0e3","Q3 Solution":"[+X1.2] Ex vivo Models","# solutions only":"2","# all b":"9","Solution Description":"Cell/tissue/organ based aging models that are predicitive, affordable and accessible."},{"tag":"[+X1.3]","color":"#d0e0e3","Q3 Solution":"[+X1.3] Multiple/Diverse Models","# solutions only":"3","# all b":"7","Solution Description":"Improve robustnest of results by using multiple models."},{"tag":"[+X1.4]","color":"#d0e0e3","Q3 Solution":"[+X1.4] Unspecified/Misc Models","# solutions only":"3","# all b":"9","Solution Description":"Better model systems for aging (unspecified how)"},{"tag":"[+X1.5]","color":"#d0e0e3","Q3 Solution":"[+X1.5] Longer Lived Models","# solutions only":"2","# all b":"4","Solution Description":"Develop longer lived animal models - more likely to be more translatable to human biology."},{"tag":"[+X1.6]","color":"#d0e0e3","Q3 Solution":"[+X1.6] Human Models","# solutions only":"2","# all b":"5","Solution Description":"Skip animals and their problems - develop human model systems (cell, tissue, organ, body, in vivo)"},{"tag":"[+X1.7]","color":"#d0e0e3","Q3 Solution":"[+X1.7] Accelerated Aging Models","# solutions only":"1","# all b":"1","Solution Description":"Accelerated aging models could speed progress... if they are representative of normal aging."},{"tag":"[+X2]","color":"#d0e0e3","Q3 Solution":"[+X2] Public Datasets","# solutions only":"22","# all b":"33","Solution Description":"Accessible and comprehensive data sets can lift all boats, accelerate progress."},{"tag":"[+X3]","color":"#d0e0e3","Q3 Solution":"[+X3] Instrumentation/Lab Tech","# solutions only":"8","# all b":"15","Solution Description":"Cheaper/better/new tools to measure biology/health/age would enable more and new studies."},{"tag":"[+X4]","color":"#d0e0e3","Q3 Solution":"[+X4] Human Cell/Tissue Bank","# solutions only":"6","# all b":"12","Solution Description":"Easy, inexpensive, and well documented samples."},{"tag":"[+X5]","color":"#d0e0e3","Q3 Solution":"[+X5] Aged Animals/Tissue Bank","# solutions only":"5","# all b":"12","Solution Description":"Easy, inexpensive, and well documented aged animals and samples. "},{"tag":"[+X5]","color":"#d0e0e3","Q3 Solution":"[+X5] Lab Automation","# solutions only":"4","# all b":"10","Solution Description":"Better/easier lab automation would enable increased throughput, higher quality, standards, collaboration."},{"tag":"[+X6]","color":"#d0e0e3","Q3 Solution":"[+X6] CS / Software","# solutions only":"5","# all b":"7","Solution Description":"Better/easier research software would enable increased throughput, higher quality, standards, collaborations."},{"tag":"[+X7]","color":"#d0e0e3","Q3 Solution":"[+X7] Gene Delivery","# solutions only":"1","# all b":"5","Solution Description":"Better delivery and gene editing tools"},{"tag":"[+X8]","color":"#d0e0e3","Q3 Solution":"[+X8] AI Tools","# solutions only":"4","# all b":"5","Solution Description":"Overcome the limits of human intelligence by building better/specialized AI systems."},{"tag":"[+X9]","color":"#d0e0e3","Q3 Solution":"[+X9] Personal Health Sensors","# solutions only":"2","# all b":"2","Solution Description":"Cars have hundreds of sensors. Most people have none. They need to be cheaper, non-invasive, easier to use."},{"tag":"[+X10]","color":"#d0e0e3","Q3 Solution":"[+X10] Syn Bio","# solutions only":"0","# all b":"1","Solution Description":"Tools to engineer cells, tissues, organs to meet our specifications."},{"tag":"[+X11]","color":"#d0e0e3","Q3 Solution":"[+X11] Computing Power","# solutions only":"1","# all b":"2","Solution Description":"More compute power unlocks new research capabilities. Also needs to be accessible."},{"tag":"[+X12]","color":"#d0e0e3","Q3 Solution":"[+X12] Health Data Platform","# solutions only":"3","# all b":"3","Solution Description":"Platform for individuals to easily analyze and share health and medical data for advancing research."},{"tag":"[+T]","color":"#b4a7d6","Q3 Solution":"[+T] Translation","# solutions only":"33","# all b":"68","Solution Description":""},{"tag":"[+T1]","color":"#d9d2e9","Q3 Solution":"[+T1] Regulatory Path","# solutions only":"19","# all b":"37","Solution Description":"A regulatory path for aging interventions / longevity medicine."},{"tag":"[+T2]","color":"#d9d2e9","Q3 Solution":"[+T2] Participant Database","# solutions only":"4","# all b":"6","Solution Description":"Database/marketplace to streamline sourcing clinical research participants."},{"tag":"[+T3]","color":"#d9d2e9","Q3 Solution":"[+T3] Regulatory Opt-Out","# solutions only":"5","# all b":"7","Solution Description":"Allow people to opt-out of medical regulations. A healthcare socioeconomic free zone."},{"tag":"[+T4]","color":"#d9d2e9","Q3 Solution":"[+T4] Intervention Testing","# solutions only":"0","# all b":"5","Solution Description":"More intervention testing, including combination therapies."},{"tag":"[+T5]","color":"#d9d2e9","Q3 Solution":"[+T5] Translation Bridges","# solutions only":"2","# all b":"2","Solution Description":"Innovation centers and funding to close the translation gap."},{"tag":"[+T6]","color":"#d9d2e9","Q3 Solution":"[+T6] Regulate Claims","# solutions only":"1","# all b":"2","Solution Description":"Require trials to make health claims in supplements, lifestyle, etc. Opportunity to design/test lower cost trials?"},{"tag":"[+T7]","color":"#d9d2e9","Q3 Solution":"[+T7] Public Trials","# solutions only":"0","# all b":"2","Solution Description":"No current mechanism to test interventions when a therapy isn't IP protectable / highly profitable"},{"tag":"[+T8]","color":"#d9d2e9","Q3 Solution":"[+T8] Rethink Trials","# solutions only":"1","# all b":"6","Solution Description":"How can we make them bigger/better/cheaper and longevity oriented."},{"tag":"[+T8]","color":"#d9d2e9","Q3 Solution":"[+T8] Data Unlocking","# solutions only":"1","# all b":"1","Solution Description":"Change policies to unlock siloed health/medical data. Require accessibility, standards and interoperability."},{"tag":"[+T9]","color":"#d9d2e9","Q3 Solution":"[+T9] Longevity Standard of Care","# solutions only":"0","# all b":"0","Solution Description":"Alternative to \"sick-care\" standards, to help create a market for longevity medicine."}]}